EX-15.1 8 asln-ex151_794.htm EX-15.1 asln-ex151_794.htm

 

Exhibit 15.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We consent to the incorporation by reference in Registration Statement Nos. 333-234405, 333-252575 and 333-254768 on Form F-3 and Registration Statement No. 333-252118 on Form S-8 of our report dated March 25, 2022, relating to the consolidated financial statements of ASLAN Pharmaceuticals Limited appearing in this Annual Report on Form 20-F for the year ended December 31, 2021.

 

 

 

 

 

 

 

 

/s/ Deloitte & Touche LLP

Deloitte & Touche LLP

Singapore

 

 

 

March 25, 2022

1